PortfoliosLab logoPortfoliosLab logo
GJAN vs. CPRA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GJAN vs. CPRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in FT Vest U.S. Equity Moderate Buffer ETF - January (GJAN) and Calamos Russell 2000 Structured Alt Protection ETF - April (CPRA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GJAN achieves a 5.88% return, which is significantly higher than CPRA's 4.58% return.


GJAN

1D
0.39%
1M
0.69%
6M
5.31%
YTD
5.88%
1Y
12.73%
3Y*
11.18%
5Y*
10Y*
ALL TIME*
12.12%

CPRA

1D
-0.02%
1M
0.32%
6M
3.95%
YTD
4.58%
1Y
8.87%
3Y*
5Y*
10Y*
ALL TIME*
8.76%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$23.06K$26.22K$32.24K
$430.42K$535.40K$1.08M

GJAN vs. CPRA - Yearly Performance Comparison


Correlation

The correlation between GJAN and CPRA is 0.69, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.69

Correlation (All Time)
Calculated using the full available price history since Apr 1, 2025

0.73

The correlation between GJAN and CPRA has been stable across timeframes, ranging from 0.69 to 0.73 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GJAN vs. CPRA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

GJAN
GJAN Risk / Return Rank: 8383
Overall Rank
GJAN Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
GJAN Sortino Ratio Rank: 8686
Sortino Ratio Rank
GJAN Omega Ratio Rank: 8888
Omega Ratio Rank
GJAN Calmar Ratio Rank: 7171
Calmar Ratio Rank
GJAN Martin Ratio Rank: 8787
Martin Ratio Rank

CPRA
CPRA Risk / Return Rank: 9898
Overall Rank
CPRA Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
CPRA Sortino Ratio Rank: 9898
Sortino Ratio Rank
CPRA Omega Ratio Rank: 9898
Omega Ratio Rank
CPRA Calmar Ratio Rank: 9898
Calmar Ratio Rank
CPRA Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

GJAN vs. CPRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for FT Vest U.S. Equity Moderate Buffer ETF - January (GJAN) and Calamos Russell 2000 Structured Alt Protection ETF - April (CPRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GJANCPRADifference
Sharpe ratioReturn per unit of total volatility

-1.97

Sortino ratioReturn per unit of downside risk

-3.97

Omega ratioGain probability vs. loss probability

1.40

1.95

-0.55

Calmar ratioReturn relative to maximum drawdown

2.51

9.57

-7.06

Martin ratioReturn relative to average drawdown

12.78

54.79

-42.01

GJAN vs. CPRA - Sharpe Ratio Comparison

The current GJAN Sharpe Ratio is 1.99, which is lower than the CPRA Sharpe Ratio of 3.96. The chart below compares the historical Sharpe Ratios of GJAN and CPRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GJAN vs. CPRA - Drawdown Comparison

The maximum GJAN drawdown since its inception was -10.60%, which is greater than CPRA's maximum drawdown of -1.69%. Use the drawdown chart below to compare losses from any high point for GJAN and CPRA.


Loading charts...

Drawdown Indicators


GJANCPRADifference

Max Drawdown

Largest peak-to-trough decline

-10.60%

-1.69%

-8.91%

Max Drawdown (1Y)

Largest decline over 1 year

-4.71%

-0.89%

-3.82%

Max Drawdown (3Y)

Largest decline over 3 years

-10.60%

Current Drawdown

Current decline from peak

0.00%

-0.02%

+0.02%

Average Drawdown

Average peak-to-trough decline

-0.77%

-0.14%

-0.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.93%

0.16%

+0.77%

Volatility

GJAN vs. CPRA - Volatility Comparison

FT Vest U.S. Equity Moderate Buffer ETF - January (GJAN) has a higher volatility of 1.52% compared to Calamos Russell 2000 Structured Alt Protection ETF - April (CPRA) at 0.44%. This indicates that GJAN's price experiences larger fluctuations and is considered to be riskier than CPRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GJANCPRADifference

Volatility (1M)

Calculated over the trailing 1-month period

1.52%

0.44%

+1.08%

Volatility (6M)

Calculated over the trailing 6-month period

4.94%

1.36%

+3.58%

Volatility (1Y)

Calculated over the trailing 1-year period

5.95%

2.16%

+3.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

7.53%

2.71%

+4.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

7.53%

2.71%

+4.82%

GJAN vs. CPRA - Expense Ratio Comparison

GJAN has a 0.85% expense ratio, which is higher than CPRA's 0.69% expense ratio.


Dividends

GJAN vs. CPRA - Dividend Comparison

Neither GJAN nor CPRA has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


GJAN and CPRA have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GJAN has higher volatility (1.52%) compared to CPRA (0.44%). In terms of maximum drawdown, GJAN dropped -10.60% vs CPRA's -1.69%.

On 1-year performance, GJAN leads with 12.73% vs 8.87% for CPRA. On fees, CPRA is cheaper at 0.69% per year. On volatility, CPRA has been the lower-risk option at 0.44%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, GJAN has performed better with a 12.73% return vs 8.87%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CPRA is cheaper with a 0.69% expense ratio, compared with 0.85% for GJAN.

GJAN and CPRA have nearly identical dividend yields, around 0.00%.

They also come from different issuers: FT Vest and Calamos. Their fees differ too: 0.85% for GJAN and 0.69% for CPRA.

CPRA currently has the higher Sharpe Ratio (3.96 vs 1.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GJAN and CPRA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer